ArticlePloS one2025
Clinical breast cancer screening uptake and associated factors among reproductive age women in Kenya: further analysis of Kenyan Demographic and Health Survey 2022.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and multilevel factors associated with clinical breast examination uptake among women in sub-Saharan Africa: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Internet use and uptake of clinical breast examination among Kenyan women of reproductive age.Scientific reports · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast cancer is a global public health problem among reproductive-age women, with an estimated 670,000 deaths in 2022. It's also a pressing health challenge in Sub-Saharan African countries, driven by late-stage diagnoses and limited healthcare access, underscoring the urgent need for early screening and treatment initiatives to combat this growing epidemic. In Kenya, the burden was also significant, and multilevel factors such as individual, household, and community level factors that influence screening uptake are undermined. Furthermore, there were no nationally representative studies. Therefore, this study aimed to assess clinical breast cancer screening uptake (CBCSU) and associated factors among reproductive-age women: further analysis of Kenyan demographic and health survey (KDHS) 2022.
methodsThis study used a weighted nationally representative sample of 16,649 women from the 2022 KDHS. A Multilevel mixed effects binary logistic regression analysis was performed and in the multivariable analysis, variables with a p-value less than 0.05 were considered statistically significant. The strength of the association was evaluated using Adjusted Odds Ratios (AOR) along with their corresponding 95% confidence intervals (CI). STATA version 17 software was to for data management and statistical analysis.
resultsThe weighted prevalence of CBCSU in Kenya was 13.91% (95% CI: 13.33, 14.44). Besides, women aged 25 to 34 years (AOR = 1.86, 95% CI: 1.57, 2.21), and 35 to 49 years (AOR = 2.87, 95% CI: 2.40, 3.42) had higher odds of CBCSU. Women with primary education (AOR = 2.14, 95% CI: 1.56, 2.94) and those with secondary or higher education (AOR = 3.09, 95% CI: 2.23, 4.28) had higher odds of CBCSU. In addition, the odds of CBCSU were higher among women with a middle (AOR = 1.41, 95% CI: 1.19, 1.67) and a rich wealth index (AOR = 2.19, 95% CI: 1.84, 2.61). On the other hand, CBCSU was lower among non-contraceptive user women (AOR 0.78, 95% CI: 0.69, 0.87). Furthermore, women in communities with a high proportion of media exposure had higher CBCSU (AOR = 1.17, 95% CI: 1.04, 1.33).
conclusionIn this study, the prevalence of CBCSU among reproductive-age women in Kenya was found to be low. Besides, factors such as age, educational status, wealth index, family planning utilization, and community media exposure were identified as significant contributors to screening uptake. Therefore, policymakers and stakeholders should design interventions that address factors contributing to low breast cancer screening uptake, particularly targeting women in areas with limited media exposure, to increase the uptake of clinical breast cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.